J. Loeper et al., TOPOLOGY INVERSION OF CYP2D6 IN THE ENDOPLASMIC-RETICULUM IS NOT REQUIRED FOR PLASMA-MEMBRANE TRANSPORT, Molecular pharmacology, 53(3), 1998, pp. 408-414
The presence of CYP2D6 at the surface of isolated rat and human hepato
cytes and its recognition by autoantibodies were reported recently. We
wondered whether the unexpected outside orientation at the plasma mem
brane could be related to topological inversion (luminal-oriented form
) of cytochrome P450 in the endoplasmic reticulum. To examine the pote
ntial role of cDNA polymorphism, a CYP2D6 variant carrying three posit
ive charges at the amino terminus (2D6ext) was constructed and express
ed in yeast. Immunoblotting, flow cytometry, and electron microscopy s
howed that wild-type CYP2D6 expressed in yeast was present on the oute
r face of the cell plasma membrane in addition to the regular microsom
al location. This location reproduces the hepatocyte situation. 2D6ext
expressed in yeast and COS7 cells seemed to be partially N-glycosylat
ed and was located at the plasma membrane surface. Nevertheless, the g
lycosylated form was not enriched in the plasma membranes compared wit
h microsomes. The relationship between CYP2D6 and 2D6ext topologies an
d catalytic competence was tested. Cumene hydroperoxide-dependent dext
romethorphan demethylation was performed on microsomal vesicles after
combined proteolysis and immunoinhibition experiments. CYP2D6 activity
was completely abolished, whereas the glycosylated and luminal-orient
ed fraction of 2D6ext remained active. This suggests that a luminal-or
iented glycosylated form is not involved in cytochrome P450 transport
to the plasma membrane. Yeast thus reproduces the unusual CYP2D6 plasm
a membrane location and orientation, which do not require sequence alt
eration, glycosylation, or even an inverted endoluminal orientation.